Cite Filings / HQL / 0001104659-25-034659

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

abrdn Life Sciences Investors Filed 2025-04-14 Acc 0001104659-25-034659

Documents 1

DEF 14A Proxy Statement , tm2512004d1_def14a.htm

Around this filing

2026-04-07 DEF 14A Proxy Statement
2025-04-17 4 10% owner sold 1,700 shares at $11.92 ($20,264)
2025-04-15 4 10% owner sold 15,400 shares at $11.67 ($179,718)
2025-04-14 4 10% owner sold 30,156 shares at $11.14 ($335,938)
2025-04-14 DEF 14A Proxy Statement
2025-04-07 4 10% owner sold 17,210 shares at an average $11.97 ($205,932)
2024-04-22 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading tm2512004d1_def14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…